Department of Neuroscience, Pharmacology and Physiology, University College London, London, UK.
Anesthesiology. 2011 Jul;115(1):144-52. doi: 10.1097/ALN.0b013e31821f6545.
Opioid-induced hyperalgesia is recognized in the laboratory and the clinic, generating central hyperexcitability in the absence of peripheral pathology. We investigated pregabalin, indicated for neuropathic pain, and ondansetron, a drug that disrupts descending serotonergic processing in the central nervous system, on spinal neuronal hyperexcitability and visceral hypersensitivity in a rat model of opioid-induced hyperalgesia.
Male Sprague-Dawley rats (180-200 g) were implanted with osmotic mini-pumps filled with morphine (90 μg · μl⁻¹ · h⁻¹) or saline (0.9% w/v). On days 7-10 in isoflurane anesthetized animals, we evaluated the effects of (1) systemic pregabalin on spinal neuronal and visceromotor responses, and (2) spinal ondansetron on dorsal horn neuronal response. Messenger ribonucleic acid concentrations of α2δ-1, 5HT3A, and μ-opioid receptor in the dorsal root ganglia of all animals were analyzed.
In morphine-treated animals, evoked spinal neuronal responses were enhanced to a subset of thermal and mechanical stimuli. This activity was attenuated by pregabalin (by at least 71%) and ondansetron (37%); the visceromotor response to a subset of colorectal distension pressures was attenuated by pregabalin (52.8%; n = 8 for all measures, P < 0.05). Messenger ribonucleic acid concentrations were unchanged.
The inhibitory action of pregabalin in opioid-induced hyperalgesia animals is neither neuropathy-dependent nor reliant on up-regulation of the α₂δ-1 subunit of voltage-gated calcium channels-mechanisms proposed as being essential for pregabalin's efficacy in neuropathy. In opioid-induced hyperalgesia, which extends to colonic distension, a serotonergic facilitatory system may be up-regulated, creating an environment that is permissive for pregabalin-mediated analgesia without peripheral pathology.
阿片类药物诱导的痛觉过敏在实验室和临床中都得到了证实,它会导致外周病理缺失时的中枢过度兴奋。我们研究了普瑞巴林(用于治疗神经病理性疼痛)和昂丹司琼(一种药物,可破坏中枢神经系统中的下行 5-羟色胺能处理)对阿片类药物诱导的痛觉过敏大鼠模型中脊髓神经元过度兴奋和内脏敏感性的影响。
雄性 Sprague-Dawley 大鼠(180-200 g)植入装有吗啡(90 μg·μl-1·h-1)或生理盐水(0.9% w/v)的渗透微型泵。在异氟烷麻醉动物的第 7-10 天,我们评估了以下两种药物的作用:(1)全身性普瑞巴林对脊髓神经元和内脏运动反应的影响,(2)脊髓昂丹司琼对背角神经元反应的影响。所有动物背根神经节中 α2δ-1、5HT3A 和 μ-阿片受体的信使核糖核酸浓度也进行了分析。
在吗啡处理的动物中,诱发的脊髓神经元反应增强到对一组热和机械刺激的反应。这种活性被普瑞巴林(至少 71%)和昂丹司琼(37%)减弱;对一组结直肠扩张压力的内脏运动反应被普瑞巴林减弱(52.8%;所有测量值 n = 8,P < 0.05)。信使核糖核酸浓度没有变化。
普瑞巴林在阿片类药物诱导的痛觉过敏动物中的抑制作用既不是神经病依赖性的,也不依赖于电压门控钙通道 α2δ-1 亚基的上调——这些机制被认为是普瑞巴林在神经病治疗中有效性的关键。在阿片类药物诱导的痛觉过敏中,这种痛觉过敏会延伸到结肠扩张,一种 5-羟色胺能促进系统可能被上调,从而创造出一种有利于普瑞巴林介导的镇痛而没有外周病理的环境。